Vaccines - Jordan

Jordan

The Vaccines market in Jordan is expected to witness significant growth in the coming years.
By 2024, it is projected to reach a revenue of US$29.16m.
This growth is expected to continue with an annual growth rate (CAGR 2024-2029) of 0.21%.
As a result, the market volume is estimated to reach US$29.47m by 2029.
In a global context, United States is anticipated to generate the highest revenue in the Vaccines market, with a projected revenue of US$29,120.00m in 2024.
Jordan has seen a surge in demand for vaccines, driven by a proactive government and a population eager to protect themselves from infectious diseases.

Key regions: Australia, Italy, France, South Korea, Brazil

Market

Region

Region comparison

Currency

Analyst Opinion

The demand for vaccines in Jordan has been increasing over the years due to various factors.

Customer preferences: Customers in Jordan have been showing a growing interest in vaccines due to the increasing awareness of the importance of preventive healthcare. The government has also been promoting vaccination programs, which has further increased the demand for vaccines. In addition, the COVID-19 pandemic has led to an increased focus on vaccines and their importance in preventing infectious diseases.

Trends in the market: The vaccines market in Jordan has been witnessing a trend towards more advanced and innovative vaccines. There has been a growing demand for vaccines that provide better protection and longer-lasting immunity. In addition, there has been a trend towards more personalized vaccines that are tailored to specific patient needs. The market has also seen an increase in the adoption of new technologies, such as mRNA vaccines, which have shown promising results in clinical trials.

Local special circumstances: One of the unique factors in the Jordanian market is the presence of a large number of refugees. This has led to an increased demand for vaccines, as refugees often come from areas with a high prevalence of infectious diseases. The government has been working with international organizations to provide vaccines to refugees and ensure that they have access to preventive healthcare.

Underlying macroeconomic factors: The Jordanian economy has been growing steadily over the years, which has led to an increase in healthcare spending. The government has been investing in healthcare infrastructure and promoting preventive healthcare, which has further increased the demand for vaccines. In addition, the country has a young population, which has a higher demand for vaccines due to their higher susceptibility to infectious diseases. Overall, the vaccines market in Jordan is expected to continue growing in the coming years, driven by these underlying macroeconomic factors and changing customer preferences.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.